The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041152 · Cited by 1,555
Self-citationInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hogendoorn, P. C. W., Athanasou, N., Bielack, S., De Alava, E., Dei Tos, A. P., Ferrari, S., Gelderblom, H., Grimer, R., Sundby Hall, K., Hassan, B., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq223 · Cited by 718
Translation of new cancer treatments from pet dogs to humans
Paoloni, M., & Khanna, C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2273 · Cited by 668
Rofstad, E. K., Mathiesen, B., Kindem, K., & Galappathi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0983 · Cited by 668
Mechanisms of Drug Resistance in Cancer Chemotherapy
Luqmani, Y. A. (2005) · Medical Principles and Practice · doi:10.1159/000086183 · Cited by 651
Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1272 · Cited by 640
Self-citationCellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H., Yoshida, Y., Tanabe, M., Ise, T., Murakami, T., Yoshida, T., Nomoto, M., et al. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00106-3 · Cited by 613
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
The chemistry, physiology and pathology of pH in cancer
Swietach, P., Vaughan-Jones, R. D., Harris, A. L., & Hulikova, A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0099 · Cited by 539
pH sensing and regulation in cancer
Damaghi, M., Wojtkowiak, J. W., & Gillies, R. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00370 · Cited by 536
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Self-citationHypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Ackerman, D., & Simon, M. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.001 · Cited by 495
Wang, T., Gilkes, D. M., Takano, N., Xiang, L., Luo, W., Bishop, C. J., Chaturvedi, P., Green, J. J., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410041111 · Cited by 493
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 437
Self-citationEffect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh305 · Cited by 435
Self-citationPharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
Rozhin, J., Sameni, M., Ziegler, G., & Sloane, B. F. (1994) · PubMed · Cited by 373
Tumor acidity, ion trapping and chemotherapeutics
Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00467-2 · Cited by 364
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362
Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 354
Self-citationHuang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352
Gillies, R. J., Raghunand, N., Garcia-Martin, M. L., & Gatenby, R. A. (2004) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2004.1360409 · Cited by 351
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Gotink, K. J., Broxterman, H. J., Labots, M., de Haas, R. R., Dekker, H., Honeywell, R. J., Rudek, M. A., Beerepoot, L. V., Musters, R. J., Jansen, G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1667 · Cited by 345
Self-citationMitochondria-dependent apoptosis and cellular pH regulation
Matsuyama, S., & Reed, J. C. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400779 · Cited by 343
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Self-citationKhanna, C., Lindblad-Toh, K., Vail, D., London, C., Bergman, P., Barber, L., Breen, M., Kitchell, B., McNeil, E., Modiano, J. F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt0906-1065b · Cited by 334
The Warburg effect and its cancer therapeutic implications
Chen, Z., Lu, W., Garcia-Prieto, C., & Huang, P. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9086-x · Cited by 318
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Wilting, R. H., & Dannenberg, J.-H. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.008 · Cited by 303
De Milito, A., Iessi, E., Logozzi, M., Lozupone, F., Spada, M., Marino, M. L., Federici, C., Perdicchio, M., Matarrese, P., Lugini, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4095 · Cited by 301
Self-citationCancer-associated lysosomal changes: friends or foes?
Kallunki, T., Olsen, O. D., & Jäättelä, M. (2013) · Oncogene · doi:10.1038/onc.2012.292 · Cited by 298
Cannibalism of Live Lymphocytes by Human Metastatic but Not Primary Melanoma Cells
Lugini, L., Matarrese, P., Tinari, A., Lozupone, F., Federici, C., Iessi, E., Gentile, M., Luciani, F., Parmiani, G., Rivoltini, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3204 · Cited by 290
Self-citationHIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
The State of Innovation in Drug Development
Kola, I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100479 · Cited by 276
Animal models and therapeutic molecular targets of cancer: utility and limitations
Cekanova, M., & Rathore, K. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49584 · Cited by 274
De Milito, A., Canese, R., Marino, M. L., Borghi, M., Iero, M., Villa, A., Venturi, G., Lozupone, F., Iessi, E., Logozzi, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25009 · Cited by 274
Self-citationDefective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
Altan, N., Chen, Y., Schindler, M., & Simon, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1583 · Cited by 265
Tumor Acidity, Chemoresistance and Proton Pump Inhibitors
De Milito, A., & Fais, S. (2005) · Future Oncology · doi:10.2217/14796694.1.6.779 · Cited by 265
Self-citationHashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265
Targeting Vacuolar H+-ATPases as a New Strategy against Cancer
Fais, S., De Milito, A., You, H., & Qin, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1805 · Cited by 264
Self-citationRegulation of vascular endothelial growth factor expression by acidosis in human cancer cells
Shi, Q., Le, X., Wang, B., Abbruzzese, J. L., Xiong, Q., He, Y., & Xie, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204500 · Cited by 259
McIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239
New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation
Swietach, P., Hulikova, A., Vaughan-Jones, R. D., & Harris, A. L. (2010) · Oncogene · doi:10.1038/onc.2010.455 · Cited by 233
Zhitomirsky, B., & Assaraf, Y. G. (2015) · Oncotarget · doi:10.18632/oncotarget.2732 · Cited by 225
Self-citationMetabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
Jiang, L., Xiao, L., Sugiura, H., Huang, X., Ali, A., Kuro-o, M., Deberardinis, R. J., & Boothman, D. A. (2015) · Oncogene · doi:10.1038/onc.2014.321 · Cited by 221
Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
Liu, F.-S. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60296-5 · Cited by 220
Rationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205
Self-citationWhelan, J. S., Jinks, R. C., McTiernan, A., Sydes, M. R., Hook, J. M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I. J., Nooij, M. A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr491 · Cited by 205
Clinical Approval Success Rates for Investigational Cancer Drugs
DiMasi, J. A., Reichert, J. M., Feldman, L., & Malins, A. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.117 · Cited by 203
Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding
Frantz, C., Barreiro, G., Dominguez, L., Chen, X., Eddy, R., Condeelis, J., Kelly, M. J. S., Jacobson, M. P., & Barber, D. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804161 · Cited by 198
Williams, A. C., Collard, T. J., & Paraskeva, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202660 · Cited by 196
The value of drug repositioning in the current pharmaceutical market
Tobinick, E. L. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.2.1303818 · Cited by 193
Peppicelli, S., Bianchini, F., & Calorini, L. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9506-4 · Cited by 192
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
Weiler, M., Blaes, J., Pusch, S., Sahm, F., Czabanka, M., Luger, S., Bunse, L., Solecki, G., Eichwald, V., Jugold, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314469111 · Cited by 188
Proton channels and exchangers in cancer
Spugnini, E. P., Sonveaux, P., Stock, C., Perez-Sayans, M., De Milito, A., Avnet, S., Garcìa, A. G., Harguindey, S., & Fais, S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.015 · Cited by 186
Self-citationTumor acidity, ion trapping and chemotherapeutics
Raghunand, N., Mahoney, B. P., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00468-4 · Cited by 182
Drori, S., Eytan, G. D., & Assaraf, Y. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.1020m.x · Cited by 179
Self-citationMarchiq, I., Le Floch, R., Roux, D., Simon, M.-P., & Pouyssegur, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 175
Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy
Barar, J., & Omidi, Y. (2013) · PubMed · doi:10.5681/bi.2013.036 · Cited by 175
IGF-binding proteins – the pieces are falling into place
BACH, L., HEADEY, S., & NORTON, R. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.05.005 · Cited by 174
Ankoma-Sey, V., & Friedman, S. L. (1998) · Liver Growth and Repair · doi:10.1007/978-94-011-4932-7_20 · Cited by 173
Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response
Mellor, H. R., & Callaghan, R. (2008) · Pharmacology · doi:10.1159/000115967 · Cited by 168
Fais, S., Venturi, G., & Gatenby, B. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9531-3 · Cited by 168
Self-citationLu, X., Qin, W., Li, J., Tan, N., Pan, D., Zhang, H., Xie, L., Yao, G., Shu, H., Yao, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3822 · Cited by 160
Targeting the Metabolic Microenvironment of Tumors
Bailey, K. M., Wojtkowiak, J. W., Hashim, A. I., & Gillies, R. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00004-x · Cited by 160
Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan
Vukovic, V., & Tannock, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.201 · Cited by 156
Manipulating tumor acidification as a cancer treatment strategy.
McCarty, M. F., & Whitaker, J. (2010) · PubMed · Cited by 145
Bellone, M., Calcinotto, A., Filipazzi, P., Milito, A. D., Fais, S., & Rivoltini, L. (2012) · OncoImmunology · doi:10.4161/onci.22058 · Cited by 144
Self-citationLuciani, F., Molinari, A., Lozupone, F., Calcabrini, A., Lugini, L., Stringaro, A., Puddu, P., Arancia, G., Cianfriglia, M., & Fais, S. (2002) · Blood · doi:10.1182/blood.v99.2.641 · Cited by 138
Self-citationThe value of drug repositioning in the current pharmaceutical market
Tobinick, E. L. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.2.1343228 · Cited by 133
Randomised controlled trials: an introduction for nurse researchers
Bench, S. D., Day, T. L., & Metcalfe, A. (2013) · Nurse Researcher · doi:10.7748/nr2013.05.20.5.38.e312 · Cited by 127
Miyazawa, K. (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.882 · Cited by 126
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
Ferrari, S., Perut, F., Fagioli, F., del Prever, A. B., Meazza, C., Parafioriti, A., Picci, P., Gambarotti, M., Avnet, S., Baldini, N., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-268 · Cited by 123
Self-citationHuber, V., Milito, A. D., Harguindey, S., Reshkin, S. J., Wahl, M., Rauch, C., Chiesi, A., Pouysségur, J., Gatenby, R. A., Rivoltini, L., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-57 · Cited by 119
Self-citationKim, S. S., Rait, A. S., Kim, E. H., Pirollo, K. F., & Chang, E. H. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.005 · Cited by 118
Swietach, P., Hulikova, A., Patiar, S., Vaughan-Jones, R. D., & Harris, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035949 · Cited by 109
The role of proton dynamics in the development and maintenance of multidrug resistance in cancer
Daniel, C., Bell, C., Burton, C., Harguindey, S., Reshkin, S. J., & Rauch, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.020 · Cited by 108
Self-citationProton pump inhibitor‐induced tumour cell death by inhibition of a detoxification mechanism
Fais, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02225.x · Cited by 107
Self-citationAdar, Y., Stark, M., Bram, E. E., Nowak-Sliwinska, P. M., van den Bergh, H., Szewczyk, G. M., Sarna, T., Składanowski, A., Griffioen, A. W., & Assaraf, Y. G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.30 · Cited by 105
Self-citationPhilip, P. A., Goldman, B. H., Ramanathan, R. K., Lenz, H., Lowy, A. M., Whitehead, R. P., Wakatsuki, T., Iqbal, S., Gaur, R., Benedetti, J., et al. (2014) · Cancer · doi:10.1002/cncr.28744 · Cited by 94
A Central Role for Hypoxic Signaling in Cartilage, Bone, and Hematopoiesis
Rankin, E. B., Giaccia, A. J., & Schipani, E. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0047-2 · Cited by 93
Song, J. H., Ge, Z., Yang, X., Luo, Q. F., Wang, C., You, H., Ge, T., Deng, Y., Lin, H., Cui, Y., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.021 · Cited by 93
Baráthová, M., Takáčová, M., Holotnakova, T., Gibadulinová, A., Ohradanova‐Repic, A., Zaťovičová, M., Hulíková, A., Kopáček, J., Parkkila, S., Supuran, C. T., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604111 · Cited by 92
Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
Azzarito, T., Venturi, G., Cesolini, A., & Fais, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.017 · Cited by 91
Self-citationHyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
Biernacka, K. M., Uzoh, C. C., Zeng, L., Persad, R. A., Bahl, A. K., Gillatt, D. A., Perks, C. M., & Holly, J. M. P. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0077 · Cited by 90
Spugnini, E. P., Buglioni, S., Carocci, F., Menicagli, F., Vincenzi, B., Fanciulli, M., & Fais, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0225-y · Cited by 88
Self-citationOncology of companion animals as a model for humans. an overview of tumor histotypes.
Porrello, A., Cardelli, P., & Spugnini, E. P. (2006) · PubMed · Cited by 87
Self-citationSpugnini, E. P., Baldi, A., Buglioni, S., Carocci, F., de Bazzichini, G. M., Betti, G., Pantaleo, I., Menicagli, F., Citro, G., & Fais, S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-221 · Cited by 87
Self-citationExpression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer.
Wu, S., Sun, C., Tian, D., Li, Y., Gao, X., He, S., & Li, T. (2015) · Europe PMC (PubMed Central) · Cited by 83
A Naturally Occurring Feline Model of Head and Neck Squamous Cell Carcinoma
Wypij, J. M. (2013) · Pathology Research International · doi:10.1155/2013/502197 · Cited by 75
Effects of oxygenation and ph on tumor cell response to alkylating chemotherapy
Siemann, D. W., Chapman, M., & Beikirch, A. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90106-e · Cited by 75
Lotz, C., Kelleher, D. K., Gaßner, B., Gekle, M., Vaupel, P. W., & Thews, O. (2007) · Oncology Reports · doi:10.3892/or.17.1.239 · Cited by 74
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Xiang, L., Gilkes, D. M., Hu, H., Luo, W., Bullen, J. W., Liang, H., & Semenza, G. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4190 · Cited by 73
Tumour–stromal interactions in acid-mediated invasion: A mathematical model
Martin, N. K., Gaffney, E. A., Gatenby, R. A., & Maini, P. K. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.08.028 · Cited by 73
Drug Resistance: Challenges to Effective Therapy
Shekhar, M. P. V. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795655921 · Cited by 72
Yu, H., Xu, Z., Chen, X., Xu, L., Yin, Q., Zhang, Z., & Li, Y. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300282 · Cited by 70
Brambilla, D., Zamboni, S., Federici, C., Lugini, L., Lozupone, F., Milito, A. D., Cecchetti, S., Cianfriglia, M., & Fais, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26285 · Cited by 64
Self-citationEllegaard, A., Groth‐Pedersen, L., Oorschot, V. M. J., Klumperman, J., Kirkegaard, T., Nylandsted, J., & Jäättelä, M. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0084 · Cited by 62
Matsubara, T., Kusuzaki, K., Matsumine, A., Shintani, K., Satonaka, H., & Uchida, A. (2006) · PubMed · Cited by 62
Multifactorial nature of tumor drug resistance.
Solyanik, G. I. (2010) · PubMed · Cited by 60
Lugini, L., Federici, C., Borghi, M., Azzarito, T., Marino, M. L., Cesolini, A., Spugnini, E. P., & Fais, S. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1046062 · Cited by 56
Self-citationMatsubara, T., DiResta, G. R., Kakunaga, S., Li, D., & Healey, J. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00199 · Cited by 49
Sax, A. T., Jenkins, D. G., Devin, J. L., Hughes, G. I., Bolam, K. A., & Skinner, T. L. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.05.011 · Cited by 46
Hulíková, A., Aveyard, N., Harris, A. L., Vaughan‐Jones, R. D., & Swietach, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547844 · Cited by 45
Lysosomotropic Properties of Weakly Basic Anticancer Agents Promote Cancer Cell Selectivity In Vitro
Ndolo, R. A., Luan, Y., Duan, S., Forrest, M. L., & Krise, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049366 · Cited by 45
Rauch, C. (2009) · European Biophysics Journal · doi:10.1007/s00249-009-0429-x · Cited by 43
Self-citationMellor, H. R., & Callaghan, R. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1598-8 · Cited by 43
TM9 and cannibalism: how to learn more about cancer by studying amoebae and invertebrates
Fais, S., & Fauvarque, M. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.09.001 · Cited by 42
Self-citationMerk, J., Rolff, J., Dorn, C., Leschber, G., & Fichtner, I. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2011.02.010 · Cited by 41
Pharmaceutical R&D Performance by Firm Size
DiMasi, J. A. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318269198f · Cited by 35
McCarthy, M. E., Auda, G., Agrawal, S., Taylor, A. C., Backstrom, Z., Mondal, D., Moroz, K., & Dash, S. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.013 · Cited by 35
Rauch, C. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0385-x · Cited by 34
Self-citationOchotny, N., Voronov, I., Owen, C., Aubin, J. E., & Manolson, M. F. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24630 · Cited by 31
Chen, D., Bobko, A. A., Gross, A. C., Evans, R., Marsh, C. B., Khramtsov, V. V., Eubank, T. D., & Friedman, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107511 · Cited by 30
Ruch, R. J., Klaunig, J. E., Klaunig, J. E., Kerckaert, G. A., LeBœuf, R. A., & LeBœuf, R. A. (1990) · Carcinogenesis · doi:10.1093/carcin/11.6.909 · Cited by 27
Regulation of Human Growth Hormone Receptor Expression by MicroRNAs
Elzein, S., & Goodyer, C. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1183 · Cited by 26
LeBoeuf, R. A., Lin, P. Y., Kerckaert, G. A., et al. (1992) · PubMed · Cited by 25
The Opportunity Cost of Capital: Development of New Pharmaceuticals
Chit, A., Chit, A., Papadimitropoulos, M., Krahn, M. D., Parker, J. L., & Grootendorst, P. V. (2015) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/0046958015584641 · Cited by 24
Inauhzin Sensitizes p53-Dependent Cytotoxicity and Tumor Suppression of Chemotherapeutic Agents
Zhang, Y., Zhang, Q., Zeng, S. X., Hao, Q., & Lu, H. (2013) · Neoplasia · doi:10.1593/neo.13142 · Cited by 23
IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (Review)
Durzyńska, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3505 · Cited by 22
Kim, S. H., Hwang, D., Park, H., Yang, E. G., Chung, H. S., & Kim, S. Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.06.017 · Cited by 14
Popov, T. M., Goranova, T., Stancheva, G. S., Kaneva, R. P., Dikov, T. I., Chalakov, I. J., Rangachev, J., Konov, D., Todorov, S., Stoyanov, O., et al. (2015) · Oncology Letters · doi:10.3892/ol.2015.3070 · Cited by 11
Gottschalk, B., & Klein, A. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1643-5 · Cited by 4
Cited by
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Tumour acidosis: from the passenger to the driver's seat
Corbet, C., & Feron, O. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.77 · Cited by 988
Modulating ROS to overcome multidrug resistance in cancer
Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.11.001 · Cited by 661
Self-citationHow the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 591
Metadata
- Authors
- Taylor, S., Spugnini, E. P., Assaraf, Y. G., Azzarito, T., Rauch, C., & Fais, S.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 23
- Pages
- 69-78
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W1132077651
- Cited by
- 259
- References
- 132
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.